findings from the relevance trial in follicular lymphoma
Published 5 years ago • 171 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
3:15
interim results of relevance trial in follicular lymphoma
-
3:52
results of relevance: frontline rituximab-lenalidomide for follicular lymphoma
-
1:25
dr. kaplan on the relevance trial in follicular lymphoma
-
0:27
copy of dr. flinn on the relevance trial in follicular lymphoma
-
1:30
dr. flinn on the relevance trial in follicular lymphoma
-
3:21
relevance study: the r-squared regimen for follicular lymphoma
-
22:46
follicular lymphoma debate: does chemotherapy have a major role to play?
-
6:50
treatment after progression in follicular lymphoma
-
1:03
relevance: rituximab and lenalidomide in fl
-
5:43
key trials in r/r follicular lymphoma
-
0:48
primary results from phase iii augment trial in recurrent indolent lymphomas
-
22:46
follicular lymphoma debate: chemotherapy no longer has a major role in the treatment
-
1:10
the relevance study: lenalidomide plus rituximab vs. rituximab-chemotherapy in the treatment of fl
-
2:03
long-term follow-up results from the zuma-1 trial in non-hodgkin lymphoma
-
3:13
untreated follicular lymphoma and the role of mrd testing
-
6:45
differential diagnosis for follicular lymphoma
-
3:45
update from soho 2020 on follicular lymphoma
-
8:40
r2 regimen: relevance and augment studies